The Department of Health and Human Services and Centers for Disease Control and Prevention today announced the AMR Challenge, a year-long effort to accelerate the global fight against antimicrobial resistance. More than 100 organizations, including the AHA, have committed to building on the progress to date. “Our shared commitment to confront this threat is critical to all American communities and companies, protecting our progress in health care outcomes, food production and even life expectancy,” said CDC Director Robert Redfield. HHS Secretary Alex Azar will launch the challenge tonight at a 7 p.m. ET event during the United Nations General Assembly in New York, which AHA Chief Medical Officer Jay Bhatt, D.O., will attend. The initiative builds on U.S. momentum since 2015 to support the National Action Plan for Combating Antibiotic-Resistant Bacteria, including antibiotic use commitments made at the White House Forum on Antibiotic Stewardship. For more on antimicrobial stewardship and resources for hospitals, visit www.aha.org

Related News Articles

Headline
In clinical trials involving 220,000 patients at 59 HCA Healthcare hospitals, algorithm-driven computerized alerts helped clinicians better identify the…
Headline
After declining in recent years, antimicrobial-resistant infections starting during hospitalization grew 15% from 2019 to 2020, the Centers for Disease Control…
Headline
The Centers for Disease Control and Prevention today updated its Core Elements for Hospital Antibiotic Stewardship Programs to reflect experience and evidence…
Headline
Antibiotic-resistant bacteria and fungi cause more than 2.8 million infections and 35,000 deaths in the United States each year, according to a report released…
Headline
The Department of Health and Human Services and Centers for Disease Control and Prevention last night celebrated nearly 350 organizations, including the AHA,…
Headline
The Food and Drug Administration yesterday approved a new antibiotic to treat adults with community-acquired bacterial pneumonia. The antibiotic, Xenleta…